Preferred Label : Supplement to Farooqui CLL 2014 Oncology Response Criteria;
NCIt related terms : FAROOQUI SUPP CLL 2014;
Alternative definition : CDISC: Supplement to: Farooqui MZH, Valdez J, Martyr S, et al. Ibrutinib for previously
untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations:
a phase 2, single-arm trial. Lancet Oncol 2014; published online Dec 31. http://dx.doi.org/10.1016/S1470-2045(14)71182-9.
(Available at http://www.thelancet.com/cms/attachment/2026086364/2045255220/mmc1.pdf.
Accessed April 27, 2016);
NCI Metathesaurus CUI : CL512493;
Origin ID : C128990;
UMLS CUI : C4288166;
Semantic type(s)
- concept_is_in_subset
